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ABSTRACT
Topically applied anti-inflammatory steroids can limit scar formation. Cortisol is an
active inhibitor of fibroblast proliferation when tested in tissue culture while cortisone is
not, but stimulates cultured fibroblasts. Wounded mice were sacrificed at various times, and
the wounds and contralateral skin were incubated with a mixture of cortisone-i ,2-°H, and
eortisol-4-'4C. The reduction of cortisol to cortisone (control 10.9%) did not differ
markedly from contralateral skin throughout tbe time period studied. The biotransforma-
tion of cortisone to cortisol (control = 41.3%) showed a biphasic response with conversion
greater than controls from 4 hours to 3 days, dropping below control levels by 6 days and
remaining depressed until 16 days. After this time, C-il ketone reduction returns to the
control range. This parallels the three phases of wound healing as follows: Production of
cortisol was higher than controls (+15%) during the substrate phase (0—5 days) and de-
creased to lower levels (—9%) in the collagen phase (5—16 days), and returned to the con-
trol range in the early phases of sear maturation (16—180 days). It appears that cortisol
levels in healing wounds are elevated at a time when they can supprcss overproliferation
of fibroblasts, but more il-keto (cortisone) steroid is present during maximum collagen
deposition. Histological studies of the tissue used for incubation show a similar pattern.
Wounded tissue taken from the substrate phase showed an intense inflammatory response.
Samples from the collagen phase showed that fibroblast proliferation had taken place and
that collagen deposition was in process. Sections of wounds in the early scar maturation
phase showed a fully formed scar. Wound tensile strength paralleled these findings. The
greatest increment in tensile strength occurred between 4 and 16 days, the period of maxi-
mum cortisone levels and the highest rate of collagen deposition. It is suggested that bio-
transformation of cortisone in peripheral tissue may serve to influence the biological ac-
tivity of cells present during the various phases of wound repair.
Beneficial inhibition of excessive sear forma-
tion by topical application of cortieosteroids
has been reported recently (1, 2). In these
studies, topical treatment with a solution of a
potent anti-inflammatory steroid (fluoeinolone
acetonide) markedly depressed scar forma-
tion, fibroblast proliferation, collagen deposi-
tion, and mueopolysaecharide formation in heal-
ing wounds of dogs (1, 2). Similar studies in
mice have shown that topical eorticosteroid
treatment in a proper dose will not suppress
wound tensile strength by the time the scar is
completely formed (2). Studies of various
topical anti-inflammatory steroids have shown
that eortieosteroids possessing an ll/3-hy-
droxyl group are active while those compounds
lacking this function have drastically reduced
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topical anti-inflammatory potency (3—6). An
in vitro assay that measured inhibition of fibro-
blast growth showed that! cortisone, having an
l1-keto group, lacks fibroblast inhibitory ac-
tivity and actually appears to stimulate fibro-
blast growth (7). On the other hand cortisol,
with its 11/3-hydroxyl group inhibits fibroblast
proliferation in vitro (8). These findings cor-
relate well with previous studies showing that
cortisol is highly active as an anti-inflamma-
tory hormone while cortisone is active only
when administered parenterally (4—6).
The process of wound healing and sear for-
mation is guided mainly by fibroblasts in the
dermis. Overproliferation of these cells and
the resulting overproduction of collagen result
in the formation of a sear. Three distinct
phases have been described in the process of
wound healing (9, 10). The first lasts from 0—5
days and is the substrate phase in which fibro-
blast proliferation is highest. The second pe-
riod is the collagen phase lasting from 5—iS
days, during which collagen is produced in the
healing wound, and the wound is resurfaced.
The third stage is the phase of sear matura-
tion which lasts approximately 15—iSO days
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post wounding. Since these cytologic and bio-
chemical changes are evident in wound healing
it became of interest for us to determine
whether or not alterations in the state of
wound tissue 1 1/3-hydroxydehydrogenase ac-
tivity on eortisol and cortisone were also tak-
ing place during the three phases of healing.
The present report deals with studies of the
inter-conversion of cortisol and cortisone in
healing wounds in mice.
MATERIALS AND METHODS
Wounding procedure. A total of 450 female
strain CBA mice, 10—14 weeks of age, were ran-
domly separated into groups of 15 animals each
for the two experiments to be reported here. On
the day of wounding an area approximately 3 x
4 cm was shaved in the middle of the back of each
mouse. The animals were anesthetized with ether
and a 4 cm cut was made with iris scissors in the
dorsal midline of each mouse's back. The wound
was then closed with two 11 mm Miehel wound
clips. Control, non-wounded mice were shaved in
the same fashion. The animals were then placed
in cages and fed Purina Laboratory Chow and
water od libitum. Wound clips were allowed to
remain in the animals that were sacrificed prior to
six days post wounding. The animals sacrificed
after this time were anesthetized on day six and
their wound clips removed. All animals were sacri-
ficed by cervical dislocation.
In the first metabolic experiment, wounded ani-
mals were sacrificed at 4, 8, 12, 18, 24, 36, and 48
hours and at 3, 4, 6, 8, 12, 16, and 20 days after
wounding. In the second experiment, animals were
sacrificed at the same times and also at 25 days
post wounding. A third group of 24 hour and 6
day mice was also run. Control, non-wounded skin
was taken from groups of animals at various times
over the experimental period. The wounds were
removed from the animals with an iris scissors in
such a way that 1—2 mm of tissue surrounding the
wound was excised. Skin from non-wounded ani-
mals was removed from the same area of the ani-
mal's back that was wounded in other groups.
Contralateral skin was removed from the sides
of some groups of mice for 4 hours, 24 hours, and
3, 6 and 12 days at a distance of at least 0.5 cm
from the wound. .411 tissue samples were imme-
diately placed iu iced buffer.
Steroid preporotion. Cortisol-4-14C and eorti-
sone-1,2-°H were obtained from New England
Nuclear Corporation. Each steroid was purified
by chromatography in the chloroform/formamide
system (11) iust prior to use. Equimolar quantities(3 )< 10 mole) of these two steroids were used,
with a ratio of H:°'C suitable to minimize count-
ing error. Each incubation contained 18,000 dpm
of cortisol-4-"C and 140,000 dpm of cortisone-i 2-
3H. The steroids were added to the incubation
flasks in 50 4 of propylene glycol.
Incubotion procedure. The skin samples were
finely minced with scissors in Krebs-Ringer phos-
phate buffer, pH 7.4. The incubations were pre-
pared in 50 ml Erlenmeycr flasks by first adding
the steroid dissolved in propylene glycol. Minced
mouse tissue (500 mg) was then added along with
10 ml of buffer. Incubations were carried out for
six hours at 37° C, with shaking. As controls, sam-
ples of steroid and buffer were incubated for the
same time period with no tissue; and "time zero"
ineubations were prepared with steroid, buffer,
tissue and 10 ml of acetone was immediately added
to prevent enzymatic reactions.
Extraction procedure and chromotography. All
ineubations were terminated by the addition of
equal volumes of acetone. The tissues were first
ground in tissue grinders with acetone to liberate
any bound or trapped steroid. The solid residue
was extracted with acetone three more times. Each
extract was filtered and the acetone was evaporated
from the pooled liquid in vacuo at 40° C. The
aqueous residue was then extracted three times
with ethyl acetate. The ethyl acetate extracts were
combined and dried to a small volume under a
stream of nitrogen. Aliquots of each extract were
taken for counting and the remainder evaporated
to dryness for chromatography in the chloroform!
formamide system for four hours with added car-
rier cortisol and cortisone. This chromatographic
technique has been previously reported (ill, 12).
Small amounts of other metabolites were observed
in these chromatograms. However there was little
radioactivity, and it was well separated from
cortisol or cortisone. Zones of radioactivity cor-
responding to added authentic, non-radioactive
cortisol and cortisone were cluted from the chro-
matograms, and aliquots were taken for scintilla-
tion counting. The remainder of the eluates was
dried and acetylated with acetic anhydride-pyri-
dine (3:1). The radioactive steroid acetates with
their acetylated reference comoounds were puri-
fied by chromatography in benzene/formamide.
Both samples of cortisune acetate and cortisol
acetate were run separately for 6 hours in this
system. The chromatograms were dried, counted
and the two reference compounds were located
with a 15. V. scanner. The identity of the steroid
acetatcs was further confirmed by crystallization
to constant specific activity, as reported by us
previously (13). These areas were eluted and
ahquots were counted in the scintillator. All sam-
ple counts were corrected for the efficiency of the
machine. A modification of the method of Mays
et al., was used to determine the amounts of "C
and 'H in each cortisol or cortisone area (14). The
interconversion of cortisol and cortisone was calcu-
lated as the percent of the total "C (or 'H) corti-
sd and cortisone that was found in the product
acetate.
Histology. Samples of each animal's wound
were taken for histological study. The samples
were fixed in buffered formalin, sectioned at 7 or
12 , thickness and stained with hematoxyhin and
eosin.
WOUND 1 l$-HYDROXYDEHYDROGENASE 467
Tensile strength measurements. Three replicate
experiments were performed, each using 55 fe-
male strain CBA mice. The mice for each experi-
ment were pooled and randomly separated into
groups. On the day of wounding, the back of each
mouse was shaved over an area approximately
3 x 4 cm. The animals were then 'anesthetized with
ether. Wounding was accomplished by making a
2 cm cut with an iris scissors in the dorsal mid-
line. The wounds were closed with two 11 mm
Michel wound clips. The clips were placed so as
to leave the center cm of the wound free from
clips. The animals were caged and fed Purina
Laboratory Chow and water ad libitum. Animals
to be sacrificed at 4 days were anesthetized on day
3 and the wound clips removed. Wound clips were
removed from all other animals on day 6. At 4,
8, 12, 16 and 20 days after treatment, groups of 11
animals were sacrificed and a 3 x 4 cm area of
the wound field removed. This tissue was pinned
to a cork board, dermis surface up, to hold it for
cutting. A razor blade cutter was used to make
two cross sections of the wound, approximately
2 mm wide by 3.5 cm long. The strips were im-
mediately stored in iced saline. Tensile strength
was determined by stretching each strip, at con-
stant speed, against a Statham strain gauge trans-
ducer (Model GL-4-250). The transducer output
was fed into a Minneapolis-Honeywell Brown
Recorder that was calibrated to give linear plots.
The apparatus was calibrated with known weights.
The tensile strength, in grams, of the two strips
taken from each wound was averaged. The proce-
dure for this method has been described elsewhere
(2).
RESULTS
Examination of the time zero controls and
the steroid-buffer incubated controls showed no
transformation of either steroid substrate. Table
I shows the metabolism of normal non-wounded
skin samples as compared with contralateral
skin. The contralateral skin samples were
taken at various time intervals after wounding.
It may be seen that the ranges of transforma-
tion of cortisone-i ,2-2H to cortisol-1 ,2-3H by
these two types of controls overlap. The same
is true for the transformation of cortisol-4-"C
to eortisone-4-'4C when normal skin and eon-
tralateral skin from wounds are compared.
Statistical comparison of both groups of data
showed no significant difference (p > 0.3). Al-
though the transformations present in contra-
lateral skin varied, especially in the C-fl re-
duction of cortisone-i, 2-3H, this variation did
not parallel the transformation of the steroid in
the wound site at the same periods of time.
Table II shows the data obtained for conver-
sion of eortisol-4-'4C to eortisone4-'4C in nor-
Type of Number of Mean Eincubation incubations (range)
Percent conversion of cortisol-4-14C to
eortisone-4-'4C
Normal skin
Contralateral
skin
6
14
12.5
(8.2—18.4)
10.9
(5.7—i7.0)
1.60
1.07
Normal skin 6 50.9
(43.1—58.3)
2.62
Contralateral 14 41.3 1.91
skin (31.8—58.3)
mal skin and in healing wounds. Means, ranges
and standard errors for the combined experi-
ments are given at the right of the table. It is
obvious that no marked change is evident in
the transformation of cortisol to cortisone in
the healing wound when these data are com-
pared with contralateral skin.
Table III gives the data for the conversion
of cortisone-i, 2-5H to eortisol-1 ,2-3H in the
three experiments. Again, the means and
standard errors are presented. It may be seen
that the transformation of cortisone to cortisol
was elevated from 4 hours to 2 days post-
wounding and dropped below control levels
from approximately the 4th until the 16th day
post wounding (see Fig. i). After 16 days, this
transformation returned to the range of the
contralateral skin controls. These data consti-
tute a tripbasic response in the transforma-
tion of cortisone-i ,2-3H to eortisol-i ,2_aH dur-
ing the process of wound healing. Comparison
with the data from various contralateral skin
samples showed that these controls did not fol-
low the same pattern evidenced in the wound.
Therefore this change in biotransformation ap-
pears to be specific for wound healing. The
pattern of the response in steroid metabolism
remained the same in the three experiments.
Figure 1 represents the data on the transfor-
mation of cortisone-i ,2'H to cortisol-i ,2—3H
obtained in wounds and control tissue and tbe
data for tensile strength of healing wounds.
TABLE I
Control incubatioas
Percent conversion of cortisone-i,2-3H to cortisol-
1, 2-3H
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TABLE II
Percent conversion of cortisol-4-1C to cortisone-4-'4C
Time of
treatment
Number of
incubations
Mean
(range) SE.
was observed. When the transformation of
cortisone to cortisol at 16, 20 and 25 days post
wounding was compared with controls, no
significant difference was found (.2 > p > .1).
At the time that tensile strength of the
1.07 wound is lowest, 1 1-hydroxydehydrogeriase
system activity favors cortisol production from
cortisone (0—3 days). As tensile strength in-
.89
creases (4—16 days), 11/3-hydroxy biotransfor-
1 12 mation is shifted to cortisone predominance,
since less reduction of cortisone occurs. Finally,
1.17 as the phase of scar maturation is reached
(16—25 days), the C-li reduction of cortisone
67 returns to normal levels.
Contral ateral
skin
Wounds
4 hours
8 hours
12 hours
18 hours
24 hours
36 hours
2 days
3 days
4 days
6 days
8 days
12 days
16 days
20 days
25 days
14
4
4
4
4
6
4
4
4
3*
0
4
4
4
3*
4
10.9
(5.7—17.0)
11.7
(9.3—13.3)
14.3
(12.2—17.3)
11.8
(9.1—14.8)
12.9
(11. 3—14 .5)
11.7
(5.7—15.8)
12.2
(10.8—13.3)
14.2
(12.9—15.1)
12.1
(11.6—12.4)
16.6
(12.6—22.7)
9.9
(8.1—11.6)
14.4
(12.4—16.7)
15.4
(12.0—18.9)
16.5
(16.3—17.9)
12.6
(12.4—12.8)
11.2
(9.7—12.5)
TABLE III
Percent conversion of cortisone-i ,2-3H to
cortisol-i ,2-3H
1.72
.61
.51 Time of
treatment
.18 Contralateral
3 i skinWounds
.65 4 hours
.88
1.67
.65
.11
.66
Number of
incubationo
14
4
4
4
4
6
4
4
4
3*
6
4
4
4
3*
4
Mean
(range)
41.3
(31.8—58.3)
54.3
(50.4—61.6)
54.6
(42.3—70.2)
63.7
(57.3—72.3)
57.6
(53.7—60.8)
55.6
(49.2—67.1)
58.6
(57.6—59.4)
53.4
(46.4—59.4)
44.8
(39.2—50.6)
31.4
(22.4—46.9)
26.8
(24.2—41.5)
29.9
(27.3—32.5)
36.3
(25.8—43.4)
33.3
(21.0—44.0)
48.5
(41.5—53.6)
46.9
(43.1—50.9)
8 hours
12 hours
18 hours
24 hours
36 hours
2 days
3 days
4 days
6 days
8 days
12 days
16 days
20 days
25 days
S.E.
1.91
2.47
6.35
3.46
1.46
2.63
0.45
3.36
2.95
7.80
6.09
1.33
4.09
5.23
4.23
1.64
* One incubation was lost from this group.
Statistically significant differences were found
between wound tissue metabolism and that of
contralateral skin. Therefore, only the mean
value for contralateral skin metabolism is
presented to simplify the graph. A statistical
analysis was performed to compare the elevated
measurements of cortisone reduction from in-
cubations at 4, 8, 12, 18, 24, 36 hours and 2
days against the values obtained in contra-
lateral skin. A group comparison test showed
a highly significant difference (p < .001). Sim-
ilarly, the values obtained for depressed C-il
reduction at 4, 6, 8 and 12 days post wounding
were compared with the contralateral controls.
Again, a highly significant difference (p < .005) * One incubation was lost from this group.
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The histological findings in wound tissue
used for these ineubations paralleled the data
for tensile strength and the three phases of
wound healing. Figure 2 shows a 24 hour old
wound, stained with hematoxylin and eosin.
At this time, the wound is in the early prolifera-
tive phase. An acute inflammatory reaction is
present with few fibroblasts or collagen fibers
being present in the wounded area. By 6 days
post wounding, the healing process had reached
the collagen phase. Figure 3 shows such a
wound. Two edges of actively proliferating
cpithelium may be seen at the site of the in-
cision (arrow). Fewer leukocytes and macro-
phages are present in the dermis than at 24
hours. There is an increase number of fibro-
blasts in the dermis and collagen fibers are
present in the wound site. Figure 4 shows a
16 day wound, which is in the early stages of
scar maturation. The thickened dermis, with
an increased number of fibroblasts and in-
creased collagen deposition is quite evident.
U,
LU
I-U,
LU
-J
U,
UiI-0
0
Epithelial repair is complete at this stage. The
sear is fully formed.
DISCUSSION
The interconversion of cortisol and cortisone
has been shown in the presence of connective
tissue cells (15). Radioactive cortisol has been
shown to specifically localize within or on the
surface of subcutaneous fibroblasts (16). Me-
tabolites with the chromatographic behavior of
eortisol and cortisone, indicating this intercon-
version, have also been shown in human skin
by Malkinson et al. (17). These authors found
no transformation of either substrate in incu-
batioiis of epidermis alone (17). The same
metabolites have also been isolated and char-
acterized by Hsia et aL, in human autopsy
skin samples (18, 19). These investigators re-
ported some metabolism of cortisol in incuba-
tions of epidermis supplemented with NADPH
(18). 1 1/3-hydroxydehydrogenase activity has
also been demonstrated histochemicallv in hu-
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FIG. 1. The biotransformation of cortisone to cortisol in healing wounds is compared
with the same transformation in the average of contralateral skin controls. Note the ele-
vated cortisol production prior to day 3 post wounding, and the depression from day 4 to
day 16. Also, the broken line represents the tensile strength of healing wounds sampled in
mice of the same strain. Tensile strength rises most rapidly during the collagen phase.
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FIG. 2. A 12 thick cross section of a 24 hour wound stained with hematoxylin and
eosin (X 75). Note the intense inflammatory reaction.
man skin by Baillie et al. (20). The studies
presented in this publication indicate marked
variations in the activity of the 116-hydroxy-
dehydrogenase system towards cortisone dur-
ing the various stages of wound healing.
Cortisol has long been known to he a more
active anti-inflammatory compound when ap-
plied to the skin topically (3, 17, 21) or when
injected into arthritic joints (22, 23) as com-
pared to cortisone. More recently, studies with
the 2 a-methyl derivatives of cortisol and corti-
sone have shown that this substitution on the
steroid molecule inhibits 1 1f3-hydroxydchy-
drogenase activity (24, 25). Compounds hav-
ing this metabolic block have been studied in
animals and in humans and the results have
shown that while 2 a-methyl cortisol is active
as an anti-inflammatory (26—28), gluconeogenic
(24, 27), lymphocytolytic (28), and sodium
retaining compound (26), 2 a-methyl cortisone
does not possess these activities. Therefore, the
state of the equilibrium of the llfl-hydroxy-
dchydrogenasc system, with regard to anti-
inflammatory steroids can confer or remove
biological activity depending on the degree of
oxidation or reduction of the steroid nucleus.
It has also has been shown that cortisol is
capable of inhibiting the proliferation of fibro-
blasts (6, 7). However, cortisone does not have
this activity in established tissue cultures and
appears to stimulate fibroblasts (7). Therefore,
the metabolic picture obtained in this study
may suggest that the biotransformation of
cortisol and cortisone during the process of
wound healing may be related to a particular
biological response. The significance of the fact
that a steroid capable of inhibiting fibroblast
proliferation is produced during the prolifera-
tive phase is unknown.
The first phase of wound healing begins after
the initial acute inflammation and continues on
for five days (9, 10). During the substrate phase
of wound healing there are large number of
leukocytes and macrophagcs present in the
wounded area (9, 10). Also, the proliferation of
fibroblasts begins during this phase, and reaches
•t:1f
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Fic. 3. A cross section of a 6 day wound, stained with hematoxylin and eosin (X 75).
Fibroblasts have proliferated and produced collagen fibers in the wnund. Epithelial repair
of the incision (arrow) is almost complete.
Fio. 4. This is a 16 day old wound. Scar formation is complete. The dermis is thickened
with exaggerated collagen and increased numbers of fibroblasts.
a peak at approximately 5 to 6 days. Recent
studies have also shown that collagen prolinc
hydroxylase activity begins to appear during
the late substrate phase and reaches a peak at
approximately 5 days following the appearance
of fibroblasts in the wound (29). It is during
this phase of wound healing that the amount of
cortisol is at its peak. Cortisol has been shown
to interfere with m-RNA activity and ribo-
somal aggregation in chick embryos (30). This
finding may account for the inhibition of col-
lagen formation by fibroblasts, or the release
of precursors from these cells (30). Electron
microscopic studies from our laboratory have
also shown decreased collagen formation with
topical corticosteroid treatment (31). Kctchum
et al., have reported that triamcinolone aceto-
nide increases the amount of soluble collagen
in wounds (32). Therefore a steroid-induced in-
crease in collagenase activity may be an alterna-
tive explanation.
The second phase of wound healing, the col-
t
-
S
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lagen deposition phase, begins at approximately
5 days post wounding and continues for ap-
proximately 10 days. It is during this time that
collagen fibers appear in the healing wound
and the wound acquires tensile strength (see
Fig. 3). Also, the process of epithelial prolifera-
tion is very active during this phase. Con-
comitantly at this time 11/3-hydroxydehydro-
genase system activity favors the production
of cortisone. It is possible that this steroid may
function to stimulate fibroblasts to actively
produce collagen. Figure 1 shows that the
tensile strength of the healing wound in mice
reaches its peak during this period. The third
phase of wound healing is the phase of scar
maturation which may continue for several
months. During this time, the collagen that has
been laid down in the wound is remodelled, the
fibers become thicker and denser and the fibro-
blast population is markedly reduced. At this
time, 1 1f3-hydroxydehydrogenase activity has
been shown to return to normal levels. The
change in cortisol oxidation is never as marked.
This may be due to the participation of other
cells in the general metabolic picture, or to
binding of this steroid by this tissue.
We have previously shown that topically ap-
plied anti-inflammatory steroids in which C-il
oxidation is hindered by specific substitutions
in the molecule in proper dosages will suppress
the formation of scars in heahng wounds of
dogs and mice (1, 2). The indices of scar for-
mation were fibroblast proliferation, production
of mucopolysaccharide staining material, the
production of collagen fibers, and the width of
the forming scar (1, 2). All of these factors
were reduced by topical corticosteroid treat-
ment without significantly reducing the tensile
strength of the healing wound by the time the
wound reached the phase of scar maturation
(1, 2). Also early beneficial effects of topical
application of potent anti-inflammatory steroids
have been shown in humans (33). The present
study suggests that the most potent endog-
enously produced anti-inflammatory steroid,
cortisol, undergoes marked changes in its me-
tabolism concomitant with the phase of wound
healing. Whether the change in the intercon-
version of these two hormones in vivo results
from a change in cellular population or the
functional state of the cells remains to be de-
termined.
Recently, Burton and Jeyes (34) have shown
similar changes in C-il oxidation of corti-
costerone or cortisol injected into pregnant
mice. The corticosteroids isolated from fetuses
at three stages of fetal development showed an
initial elevated 11,6-reduction, with a subse-
quent increase in 11 oxidation as the fetus
grows and a return to increased reduction close
to term (34). Thus, the similar changes that
we have observed in wound cellular 11,6-re-
ductase activity may simply mirror the growth
of the repair tissue. However, the present
findings suggest that a relevant functional
state of the molecule for a particular period of
the process of wound healing (fibroblast in-
hibition or stimulation) is produced by the
metabolic processes of the cells in the wound.
Since very low levels of substrate were used, it
is possible that the physiologic function of low
concentrations of cortisol differs from that
found in tissue culture studies where this
steroid inhibits fibroblast proliferation. Other
processes, such as generalized inflammation and
Icukocyte invasion are involved in wound heal-
ing. These data show another means by which
peripheral steroid biotransformation may serve
to regulate the activities of cells.
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